MENU

HKMPF Price Prediction, Hikma Pharmaceuticals plc. AI Recommendations

A.I.Advisor
published Dividends

HKMPF is expected to pay dividends on September 20, 2024

Hikma Pharmaceuticals plc. HKMPF Stock Dividends
A dividend of $0.32 per share will be paid with a record date of September 20, 2024, and an ex-dividend date of August 15, 2024. The last dividend of $0.47 was paid on May 03. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 3.28B. The market cap for tickers in the group ranges from 246 to 77.48B. ZTS holds the highest valuation in this group at 77.48B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 93%. INNPF experienced the highest price growth at 11,344%, while ECGS experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 60
SMR Rating: 86
Profit Risk Rating: 90
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1 New Burlington Place
Phone
+44 2073992760
Employees
8800
Web
https://www.hikma.com